Venator Capital Management’s Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant AUS.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-40,000
Closed -$404K 68
2021
Q2
$404K Buy
+40,000
New +$410K 0.14% 50

Other funds holding AUS.U

Venator Capital Management's AUS.U Position: Q3 2021 in Review

Venator Capital Management sold out of Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant (AUS.U) in Q3 2021, closing a stake of 40,000 shares — an estimated $404K sold.

Venator Capital Management first reported a position in AUS.U in Q2 2021 and held it in 1 quarter. The position peaked at $404K in Q2 2021. 22 funds tracked by Wall St. Rank hold AUS.U as of Q3 2021.

  • Venator Capital Management reported no remaining Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Venator Capital Management sold 40,000 Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant shares in Q3 2021, an estimated $404K.
  • Venator Capital Management first reported a position in Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant in Q2 2021 and held it in 1 quarter.
  • Venator Capital Management's Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant position peaked at $404K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant as of Q3 2021.

Based on Venator Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.